Please login to the form below

Not currently logged in
Email:
Password:

Patrick Fabbio named CFO at electroCore

He joins from NPS Pharmaceuticals where he was VP finance

edit-patrick-fabbio-of-electrocoreUS-based electroceutical healthcare company electroCore has named Patrick Fabbio as chief financial officer.

Fabbio has over 20 years of financial leadership experience in public and private life science and pharmaceutical companies, most recently as VP finance for NPS Pharmaceuticals.

During his time at NPS, he led the build-out of the global finance department and supported its $5.2bn sale to Shire in February of this year.

Prior to NPS, Fabbio served in a range of senior financial positions including VP finance at Catalent Pharma Solutions, CFO at Ikano Therapeutics and senior corporate finance, commercial and transactional roles at Sanofi.

ElectroCore founder and CEO JP Errico commented: "I am delighted that Pat has joined the electroCore team. Pat is a senior executive with broad experience in general management and finance. He has a strong track record of success in corporate finance in the healthcare sector.”

10th June 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics